NCT03632616
Quality of Life Assessment of Chronic Pancreatitis Endoscopic Interventions
UNKNOWN
Not specifiedAges 18+ObservationalUniversity of Colorado, DenverInvestigator-initiated
~500 participants
Updated 2024-05-22 on ClinicalTrials.gov
What's tested:PANQOLI (quality of life instrument)
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Quality of Life using the PANQOLI (PANcreatitis Quality of Life Instrument)
Measured over The outcome will be measured at 1, 3, and 6 months post-intervention.
Conditions
Where it's being run
2 sites across 2 statesColorado1
Maryland1
Study leadership
- Raj J Shah, MD · PRINCIPAL_INVESTIGATOR · Professor of Medicine; Director, Pancreas and Biliary Endoscopy
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients with painful chronic pancreatitis, defined as either 1) the presence of pancreatic calcifications on cross-sectional imaging, 2) morphologic changes consistent with the Rosemont criteria on endoscopic ultrasound, or 3) endoscopic pancreatic function test results consistent with decreased pancreatic function.
Exclusion
Pregnant females
Prisoners
Patients under the age of 18
Patients lacking the capacity to consent
What this trial measures
- Change in Quality of Life using the PANQOLI (PANcreatitis Quality of Life Instrument)The outcome will be measured at 1, 3, and 6 months post-intervention.
The primary outcome will be the change in quality of life using the PANQOLI (PANcreatitis Quality of Life Instrument) after endoscopic intervention.